Invention Grant
US09192666B2 Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy
有权
使用抗c-Met抗体和FGFR抑制剂联合治疗治疗癌症的方法
- Patent Title: Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy
- Patent Title (中): 使用抗c-Met抗体和FGFR抑制剂联合治疗治疗癌症的方法
-
Application No.: US14242684Application Date: 2014-04-01
-
Publication No.: US09192666B2Publication Date: 2015-11-24
- Inventor: Bo Gyou Kim , Ji Min Lee , Kyung Ah Kim , Yun Ju Jeong
- Applicant: Samsung Electronics Co., Ltd.
- Applicant Address: KR Suwon-Si
- Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee Address: KR Suwon-Si
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: KR10-2013-0035293 20130401; KR10-2013-0161685 20131223
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/30 ; C07K16/28 ; A61K31/506 ; A61K31/519 ; A61K39/00
Abstract:
Provided is a method for prevention or treatment of a cancer, comprising co-administering (a) an FGFR inhibitor and (b) an anti-c-Met antibody or antigen-binding fragment thereof to a subject in need thereof, wherein the anti-c-Met antibody or the antigen-binding fragment thereof specifically binds to an epitope comprising 5 or more contiguous amino acids within the SEMA domain of c-Met protein.
Public/Granted literature
- US20140308284A1 METHOD OF COMBINATION THERAPY USING ANTI-C-MET ANTIBODY AND FGFR INHIBITOR Public/Granted day:2014-10-16
Information query
